PMC:7344504 / 112-819
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
17 | 100-108 | Species | denotes | patients | Tax:9606 |
18 | 412-419 | Species | denotes | patient | Tax:9606 |
19 | 446-467 | Species | denotes | Aspergillus fumigatus | Tax:746128 |
20 | 378-389 | Species | denotes | Aspergillus | Tax:746128 |
21 | 295-303 | Chemical | denotes | triazole | MESH:D014230 |
22 | 362-367 | Chemical | denotes | azole | MESH:D001393 |
23 | 493-501 | Chemical | denotes | triazole | MESH:D014230 |
24 | 687-695 | Chemical | denotes | triazole | MESH:D014230 |
25 | 0-8 | Disease | denotes | COVID-19 | MESH:C000657245 |
26 | 20-43 | Disease | denotes | pulmonary aspergillosis | MESH:D055732 |
27 | 121-144 | Disease | denotes | pulmonary abnormalities | MESH:D008171 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T3 | 0-8 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 30-43 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
T5 | 45-49 | Disease | denotes | CAPA | http://purl.obolibrary.org/obo/MONDO_0007163 |
T6 | 434-438 | Disease | denotes | CAPA | http://purl.obolibrary.org/obo/MONDO_0007163 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 54-55 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 212-213 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 410-411 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T5 | 491-492 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6 | 564-569 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | faced |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 231-241 | Chemical | denotes | antifungal | http://purl.obolibrary.org/obo/CHEBI_35718 |
T2 | 295-321 | Chemical | denotes | triazole antifungal agents | http://purl.obolibrary.org/obo/CHEBI_86426 |
T3 | 295-303 | Chemical | denotes | triazole | http://purl.obolibrary.org/obo/CHEBI_38597 |
T4 | 304-321 | Chemical | denotes | antifungal agents | http://purl.obolibrary.org/obo/CHEBI_35718 |
T5 | 362-367 | Chemical | denotes | azole | http://purl.obolibrary.org/obo/CHEBI_68452 |
T6 | 493-501 | Chemical | denotes | triazole | http://purl.obolibrary.org/obo/CHEBI_38597 |
T7 | 687-695 | Chemical | denotes | triazole | http://purl.obolibrary.org/obo/CHEBI_38597 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 0-177 | Sentence | denotes | COVID-19-associated pulmonary aspergillosis (CAPA) is a recently described disease entity affecting patients with severe pulmonary abnormalities treated in intensive care units. |
T5 | 178-250 | Sentence | denotes | Delays in diagnosis contribute to a delayed start of antifungal therapy. |
T6 | 251-398 | Sentence | denotes | In addition, the emergence of resistance to triazole antifungal agents puts emphasis on early surveillance for azole-resistant Aspergillus species. |
T7 | 399-535 | Sentence | denotes | We present a patient with putative CAPA due to Aspergillus fumigatus with identification of a triazole-resistant isolate during therapy. |
T8 | 536-707 | Sentence | denotes | We underline the challenges faced in the management of these cases, the importance of early diagnosis and need for surveillance given the emergence of triazole resistance. |